An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation‐Negative Pancreatic Ductal Adenocarcinoma

PURPOSE. Oncogenic mutations in the KRAS gene are a well‐known driver event, occurring in >95% of pancreatic cancers. The objective of this study was to identify driver oncogene aberrations in pancreatic cancers without the KRAS mutation. METHODS. Whole‐exome and transcriptome sequencing was perf...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Shimada, Yoko, Kohno, Takashi, Ueno, Hideki, Ino, Yoshinori, Hayashi, Hideyuki, Nakaoku, Takashi, Sakamoto, Yasunari, Kondo, Shunsuke, Morizane, Chigusa, Shimada, Kazuaki, Okusaka, Takuji, Hiraoka, Nobuyoshi
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2017
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330701/
https://ncbi.nlm.nih.gov/pubmed/28167572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0194
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados